A plaque assay is described in which cytolytic activity of lymphocytic choriomeningitis virus (LCMV) is observed at low but not at high concentrations of infecting virus. Quantitation of the interference at high virus concentrations is detailed. Use of this assay during the course of the LCMV infection in L cells has shown that an interfering component is produced in abundance after the initial peak in infectivity in the medium has been reached. Thereafter the ability of the virus stock to form infective centres declines while the interference activity rises. Coinfection of L cells with high concentrations of one LCMV strain and low concentrations of any other tested strain prevents cellular destruction. When small virus inocula are used interference can be observed within single' bull's eye' plaques which exhibit concentric rings of lysed and intact cells. Simultaneous infection of L cells with an auto-interfering concentration of LCMV does not interfere significantly with plaque formation by mengo, vaccinia, and vesicular stomatitis viruses, but reduces four-to fivefold the number &plaques formed by the Amapari and Parana viruses related to LCVM. Interferon does not play a role in the system described. The physical and the immunological data on the interfering substance are consistent with the hypothesis that defective-interfering virus particles are present in LCMV tissue culture stocks.
INTRODUCTION
Although lymphocytic choriomeningitis virus (LCMV) has been studied for almost 4o years, the molecular intricacies of its infectious process remain obscure. Attempts at biophysical analysis have been impeded by the exceptional lability of virus to physical and chemical agents, while biochemical and genetic studies have been prevented by the low infectivity of LCMV stocks and by the inability to infect synchronously all cells of a population.
The possibility that virus interference could be an important regulatory factor in the process of LCMV infection has received little attention, even though there have been some suggestive reports. It is known that LCMV has the capacity to produce persistent infections in cell cultures which, after successive passages, eventually stop producing virulent LCMV (Benson, I96I; I967; Slenczka & Tees, r969; Trowbridge & Pfau, 197o) . These cultures continue to release LCM immunogen of high moleculal weight that fails to kill mice or form plaques but interferes in freshly infected cells with the synthesis of standard LCMV. LCMV specific interference also has been reported in another type of study in which lymph node cells, freshly isolated from mice congenitally infected I78 R.M. WELSH AND C. J. PFAU with a viscerotropic strain of LCMV, were refractory to challenge by a neurotropic strain (Traub & Kesting, 1963) . The mechanism of LCMV interference in tissue culture has not yet been elucidated, whether it be the confirmed homologous type or the disputed heterologous type (Hotchin & Cinits, I958; Traub & Kesting, ~963; Wagner & Snyder, I962; Veltri & Kirk, I967; Trowbridge & Pfau, t97o; Welsh & Pfau, I97o) . This reflects the lack of techniques available for investigation. The BHK 21 / 13 S LCMV plaque assay, introduced by Sedwick & Wiktor (~967) and developed by Pulkkinen & Pfau (I97o) , has provided a precise method for the titration of LCM virus and LCM-infected cells (infective centres). In this paper we present a simple and quantitative L cell plaque assay for the demonstration of homologous interference. Using these two techniques, results have been obtained which suggest strongly that biologically active, defective virus particles are controlling factors in LCMV synthesis and infective centre formation.
METHODS
Viruses. The LCM strains used in this study were ARMSTRONg, CA~37I, FORT~ER, M-7, TRAtm, UBC, WC~' and WE. The origins and passage histories of these strains have been described (Pulkkinen & Pfau, ~ 970) . The strains of VSV (INDIANA) and of vaccinia (wR) were those used in previous studies (Pfau & Camyre, I968; Volkert, Larsen & Pfau, I964) . The small plaque variant of mengo virus (Franklin, I96~ ) was from D. Baltimore. The Tacaribe viruses, Amapari and Parana (Rowe et al. I97ob) , were from K. M. Johnson.
Cells. BHK2I/I 3 S cells were propagated in suspension and used in an accurate suspension plaque assay (Pulkkinen & Pfau, I97o) . This system was used for virus titration unless otherwise stated. L-929 cells were grown on monolayers in 32 oz. prescription bottles (Camyre & Pfau, I968) .
L cell interference assay. L cells grown in prescription bottles were dispersed with trypsin, seeded on to small plastic tissue culture dishes (Falcon No. 3oo2) , and incubated at 37 ° in a humidified CO2 atmosphere. The culture fluid was Eagle's minimal essential medium (MEM) supplemented with Io % calf serum. After formation of confluent monolayers, the medium was decanted and each plate received either I ml. from a virus dilution series or I ml. of a preparation of interfering virus plus o.I ml. from a dilution series of challenge virus. After incubation for I hr, 5 ml. of plaque medium (PM) were poured gently over the cells on each plate. In some cases the monolayers were washed 3 times with r ml. of MEM before addition of the PM. The PM consisted of 2 x Basal Eagle's medium supplemented with 8 % heatinactivated (56 °, 3o rain.) foetal calf serum diluted ~ : ~ with 1% agarose; the concentration of sodium bicarbonate was I g./1. When the PM solidified, the plates were placed in a humidified CO2 incubator. The COs concentrations for these studies ranged from 2"5 to 8 %. After incubation, each plate was stained with 2 ml. of PM containing I/Io,ooo neutral red. Plaques were observed from 6 hr to ro days after staining. Plates infected with only LCMV were routinely stained 4 days after infection. Heterologous virus plaques were stained and counted as follows: mengo virus, day 2; VSV, day I or 2; vaccinia virus, day 5; Parana virus, day 6; Amapari virus, day m.
Growth of LCMV in L cells. Confluent (3 to 4 x ~o ~ cells/plate) monolayers of L cells were each infected for I hr with I ml. of virus suspension. The monolayers were then washed 3 times with I ml. of MEM and incubated for up to 72 hr under 5 mI. MEM. For growth studies, o.I ml. aliquots were withdrawn from the culture fluids of infected plates, diluted tenfold in MEM, and frozen at -7 o° until use. For the interference studies, monolayers were identically infected, and at intervals of I2 hr the entire supernatant fluid from any given plate was harvested and frozen. A standard virus stock is our term for an LCMV stock prepared by undiluted serial passage of LCMV in L cells. Standard stocks were routinely harvested from 48 to 72 hr after infection.
Infective centre (IC) assay. L cell monolayers were each infected with I ml. of virus stock for I hr, washed 3 times with I ml. of MEM, dispersed with trypsin, and resuspended in 5 ml.
MEM. The cells were centrifuge-washed 5 times in the cold (4 °) at 225g (IOOO rev./min.) for 5 min.). The pelleted cells were always resuspended in 5 lnl. MEM. After washing, the samples were directly plated on to the surfaces of BHK suspension assay plates. At least 9o ~ of the resulting p.f.u, were sensitive to sonic oscillation for ~ min. Further details of the infective centre assay have been published (Welsh et al. ~97I) .
Sedimentation of LCMV. LCMV was subjected to differential centrifugation in a Spinco L2-65 ultracentrifuge. The samples were centrifuged at IO,OOO rev./min, for 2o min. in the SW-39 rotor. The resulting supernatant fluids were then centrifuged at 39,ooo rev./min, for 37 min. in the same rotor. This treatment sediments all LCMV (Pfau, I965) . The resuspended virus pellets were then subjected to sonic oscillation for I min. to break up virus aggregates and recover the initial infectivity (Pfau & Camyre, I967) .
Interference after physicaland chemical treatment. LCM-uBc virus samples of infectivity of
to 2 x ~o r p.f.u./ml, were treated in various ways and then tested for interfering ability on L cell monolayers. Plates were infected with a m -x dilution of treated LCMV or medium only and challenged with tenfold dilutions of untreated virus. Plates were examined 4 days after infection for the appearance of plaques and cytolytic activity. Treatments were as follows:
(I) Ultraviolet (u.v.) irradiation; virus samples were placed in cold tissue culture dishes 2o cm. from Westinghouse Sterilamp 78aL-2o light source for ~ min.
(2) Filtration; virus samples were tested after passage through a Millipore filter of 25/~m. pore size.
(3) Heat; 6o °, ~o min. (4) Neutral red; virus samples were exposed to 5 x To -6 g./ml, neutral red (Fisher Scientific Co.) for 2 hr at 4 ° in the light. Since neutral red has been shown to inactivate LCMV in the light (Pulkkinen & Pfau, I97o) , plates were infected in the dark with only background u.v. illumination and then incubated in the dark until stained.
(5) Immune and normal sera; virus samples were exposed to 2o ~ sera for 3o min. at 37 °.
RESULTS

Inhibitory effects in plaque assays
All tested strains of LCMV (ARMSTRON6, CA I37I, FORTNER, M-7, TRAUB, UB¢, WCV, WE) formed plaques on the L cell monolayers. At high concentrations of infecting virus, all cells remained intact and assimilated neutral red. With decreasing concentration of infecting virus the number of plaques increased rapidly to a maximum and then decreased to zero. Cells were lysed in the plaque areas. The virus concentration was proportional to plaque number on plates with fewer than ~oo plaques. The size and number of plaques were markedly inhibited when more than Ioo appeared on a plate. The plaque number and degree of interference on a plate did not depend on whether or not the inoculum was removed before addition of the agarose overlayer.
Areas resistant to cell lysis were observed within plaques when plates were incubated at CO2 tensions greater than 4 ~. These 'bull's eye' plaques showed two or three, but some- times up to seven, concentric rings of lysed and intact cells. The centres of these plaques were either turbid or lysed (Fig. 0 . Although the 'bull's eye' feature appeared on plates with as many as 2o0 plaques, the morphology was most distinct on plates with fewer than 50. This characteristic morphology was sometimes evident soon after staining but frequently took several days to develop. Our results showed that low concentrations of LCMV induced plaque formation on L cells, but high concentrations of the virus had no visible effect on the cells. We wished to determine if this interference existed between strains of LCMV. L cell monolayers were infected with high concentrations of one strain and challenged with low concentrations 0 9 to 3oo p.f.u.) of another strain. All possible pairs of strains cA I37I, M-7, UBC and wE virus were used in this experiment. No plaques appeared on plates receiving only the interfering virus, while plates receiving only the challenge virus exhibited the expected number of plaques. No plaques appeared on the plates treated with both interfering and challenge virus, indicating that the phenomenon was not strain specific.
Estimation of interference activity
We observed that virus stocks of similar infectivity (p.f.u./ml.) differed at high concentrations in their cytolytic activity. The interference activity of these virus preparations was measured by infecting plates with a series of twofold dilutions. The reciprocal of the limiting dilution at which plaques first appeared was recorded as the interference activity.
Interference in infective centre formation and virus synthesis
The observation of cytolytic interference at high virus concentrations led us to question whether similar phenomena occurred at the levels of infective centre formation and virus synthesis. A standard LCMV strain u~c stock, harvested 72 hr after infection, was tested for its ability to form infective centres on L cells. In duplicate experiments, although the input multiplicity of the undiluted stock was 1.5 p.f.u./cell, only about one cell in ten scored as an infective centre, while essentially the same number of infective centres was scored when the stock was diluted tenfold before infection. Successive tenfold dilutions of the infecting stock indicated a proportional number of infective centres. Since these results demonstrated an inhibition in the infective centre forming capacity of the undiluted standard stock, we next determined how dilutions of stock used as inocula would influence the growth of various LCMV strains. Three LCMV strains, selected on the basis of distinct plaque morphology (Pulkkinen & Pfau, 197o ) , and each passed undiluted several times in L cells, were used to infect L cells at different input multiplicities. The results (Fig. 2A, B, C) showed that when these standard virus stocks were diluted before infection, higher peaks of infectivity were obtained. Similar results occurred with LCMV-uBc in non-interferon producing Vero cells and with three times plaque-purified LCMV-uBc (after three passages in L cells). This increase in infectivity was greater than tenfold when LCM-uBc or LCM-TRAUB were diluted tenfold before infection. Two subsequent tenfold dilutions in this experiment increased twofold the infectivity of LCM-uBc, and enhancements up to fourfold have been observed in similar experiments. The increase in infectivity with the slow-growing LCM-cA t 371 was not as great as that for LCM-u~c and LCM-TRAUB, but the I/Jo diluted stock produced a peak of twice the infectivity of that produced by the undiluted stock: this small increase was consistent in three separate experiments.
Determinants of lymphocytic choriomeningitis interference
The 72 hr harvests from the above LCMV growth curves (Fig. 2) were tested for their abilities to form infective centres. With each strain, most cells were scored as infective centres when a stock grown from a very low input m.o.i, was used as inoculum (Table I) . The LCM-uBc stocks were analysed in greater detail by testing dilutions of each sample. Again, there was little difference between the infective centre forming capacities of undiluted and tenfold diluted samples. The harvests at 72 hr from the growth studies shown on Fig. 2 were analysed for production of infective centres (see Methods). For each LCMV strain/I ml. of undiluted stock, grown from various tenfold dilutions, was inoculated on to L cell monolayers of relatively constant density: the only exception was the IO s stock of uBc (*), which was analysed separately and inoculated on to 30 % more cells than the other uBc stocks. Hr. after infection Fig. 3 . Infective centre formation and interference of LCM-uBc virus in L cells. A standard LCMuBc virus stock was diluted tenfold and inoculated on to a series of L-cell monolayers. The medium from duplicate samples was harvested every I z hr and assayed for infectivity (©, O) . These harvests were then tested for their abilities to form infective centres on L cells (±, i,) and assayed for interference (@, O) using the L cell interference plaque assay. Symbols refer to two separate experiments.
Production of interference during growth of LCM-uBc
Because the results indicated that LCMV exhibits marked homologous interference in plaque production and infective centre formation, we attempted to correlate these two indicators of interference. L cell monolayers were infected with I ml. samples of a tenfold diluted LCM-uBc stock. Culture fluid samples were harvested in duplicate at I z hr intervals after infection and analysed for infective centre formation and interference activity (Fig. 3) . Following the development by 36 hr of peak infectivity in the culture fluid (BHK assay for p.f.u.) the interference activity continued to rise. As the interference activity rose from 32 to 128, a precipitous drop was detected in the ability of stocks to form infective centres. Similar results were obtained using an undiluted LCM-uBc inoculum for the growth study. Such results from a number of experiments showed consistently that the peak infective centre forming capacity occurred at or probably just before the initial peak in virus infectivity. Once this virus infectivity peak was reached there was a rise in interference activity but a rapid drop in the ability to form infective centres. 
Transmissibility of an interfering component
We wished to determine if the depression in synthesis of LCMV shown in the growth curves was due only to abortive synthesis (auto-interference) by infection at high multiplicity or was due to an interfering component carried with virus in the infecting medium. Two LCM-uBc stocks were prepared of which one was a standard stock (UBC-A, 3"2 × I0 6 p.f.u./ml.) resulting from several serial passages of undiluted virus. The other was prepared by serial passages of diluted virus and finally harvested before peak infectivity was reached in a passage of undiluted virus (UBC-B, 1"7 x lo 7 p.f.u./ml.). UBC-A and UBC-B formed ~o and 77 infective centres, respectively. It was found that undiluted UBC-B produced stocks with sixfold higher peak infectivity at 36 hr than did UBC-A used at lower multiplicity of original infection. At comparable m.o.i. UBCm produced harvests of ninefold higher peak infectivity. When UBC-A and UBC-B were mixed and then used to infect cells simultaneously, the virus yield was nearly indentical to that from cells infected only with UBC-A, but far below the yield from cells infected only with UBC-B. This indicated that there was an interfering component in stock UBC-A that could interfere with virus synthesis by UBC-B infected cells. Thus, when undiluted stocks were used to infect cells, the inhibition of virus synthesis was not due simply to the high p.f.u, input but was due to some other component of the medium.
Effect of LCMV on heterologous virus plaque formation
Plates infected with high concentrations of LCMV strain UBC were challenged with low concentrations of heterologous viruses. This treatment sometimes slightly inhibited by up to 3o ~ the number and size of plaques formed by VSV and mengo virus. The extent of inhibition in six separate experiments was inconsistent; on some occasions (Welsh & Pfau, 197o) there was no inhibition of plaque size and number. The interfering effect with VSV was transient; plaque size and number frequently rose to the level of the control plates if final counts were made t to 2 days after staining. The infection of cells with VSV 24 hr after infection with LCMV did not change the results significantly. Plaque production by vaccinia virus was consistently uninfluenced by the presence of LCMV.
However, high concentrations of LCM-uBc virus interfered significantly with the plaque production of the LCM-related Tacaribe viruses. Co-infection with LCMV led to fewer (four-to fivefold), smaller, and less distinct plaques due to Amapari or Parana virus. Amapari virus alone exhibited an homologous interference pattern of the LCM-type in that there was no cytolytic activity on plates infected with high concentrations of Amapari virus, and, like LCMV, plaque size was greater following infection at lower multiplicity. Parana 
Nature of the interfering component
Samples of LCM-uBc virus were subjected to physical and chemical treatments and then tested for change in the interfering component. Samples of LCMV subjected to heat, neutral red, or immune serum (Table z) lost the ability to interfere with plaque formation by challenge virus. The filtrate of the LCMV sample also lacked interfering activity. Samples exposed to u.v. irradiation or treated with control serum maintained their interfering capacities. Interference activity was removed after differential centrifugation of the supernatant fluid of auto-interfering virus stocks. The residual p.f.u, in the supernatant fluids formed distinct plaques when plated undiluted on to L cells.
These results indicate that the interfering substance was of high molecular weight and had properties similar to those of LCMV. It was possible, however, that the inability of certain virus stocks to form infective centres efficiently was due to interference with adsorption by cellular debris or to the removal of an adsorption cofactor from the medium by cellular metabolism. The interfering component of a standard LCM-tJBC virus stock (2'5 x I o v p.f.u./ ml.) that formed zo ~ infective centres was separated successfully from the medium by differential centrifugation under conditions that separated LCMV. The virus pellet was resuspended without loss in either fresh MEM, metabolized MEM (MEM that had overlaid an actively growing monolayer of L cells for 48 hr), or the original stock medium. All the resuspended pellets retained their abilities to form about 2o ~ infective centres. Thus, interference at the level of infective centre formation was a function of particles that sedimerited with the normal LCM virus particles and could not be attributed to cellular debris or to the loss of an adsorption cofactor.
DISCUSSION
The results demonstrate that LCMV induces homologous interference at the level of cytolytic activity in L cells (Fig. I) , capacity to form infective centres (Fig. 3) and virus synthesis under liquid medium (Fig. z) . LCMV also interferes with the plaque production by the arenaviruses related to LCMV (Rowe et al. I97oa) , Amapari and Parana. On the basis of physical and biological properties the interference cannot be attributable to interferon. The interfering substance is heat-labile with size and sedimentation properties similar to that of the LCMV particle. The unrelated, interferon-sensitive mengo, vaccinia, and vesicular stomatitis viruses are not affected in this system. The interfering substance shares with the infectious LCMV particle the sensitivity to LCM immune serum and to neutral red, but, unlike the infectious virus particle, its activity is relatively resistant to u.v.-irradiation.
Defective-interfering (DI) virus particles have been described in several systems and have recently been reviewed by Huang & Baltimore (I97O) . Those that have been studied in detail share the following biological properties: they contain normal virus structural protein; they do not contain the entire virus genome; they can only reproduce in the presence of helper virus; and they interfere specifically with the intracellular replication of non-defective homologous viruses. When DI particles are present in virus stocks, diluted passages in cell lines result in the production of many more infectious, standard virus particles than when the stocks are passed undiluted (von Magnus, I954; Cooper & Bellett, I959 Our results suggest that LCMV is a DI particle-producing system. The yon Magnus phenomenon is observed in the LCMV growth curves (Fig. 2) and there is a transmissible interfering component in virus stocks that is not the infectious, intact virus particle. The studies indicate that the interfering component is of similar physical nature to the infectious virus particle. The observation that u.v.-inactivated LCMV preparations interfere indicates that the intact virus genome may not be necessary for manifestation of the effect. The increase in interfering activity (Fig. 3) which accompanies the decrease in infective centre forming ability of the culture fluid from infective cells, may indicate the advent of synthesis of DI virus particles, although the interference could be due to heat inactivated virus. That heat-inactivated virus alone is responsible for interference is unlikely because particles sedimented from the culture fluid of LCMV-persistently infected cells, which contain no detectable infective virus, also interfere with virus synthesis (Lehmann-Grube et al. 1969; Welsh, 197 I) . In these cultures the synthesis of almost only the interfering particles indicates that they are not produced by heat inactivation of standard virus. Further studies in our laboratory have shown that these particles prevent the formation by LCMV of infective centres and plaques (Staneck, Welsh & Pfau, 1971 ) . Another indication that the interfering particles are defective is that we have been unable to demonstrate their replication in the absence of standard LCMV as helper (Trowbridge, 1970; Welsh, 197 I) .
The elucidation of the phenomenon of LCMV interference may contribute to our understanding of the process of infection by LCMV. It is obvious that massive virus-induced cytolysis cannot lead to a persistent in vivo infection. The suppression of cytolysis by DI particles could be of fundamental importance in establishing the carrier state. Our results should not necessarily be related to the high dose inhibitory phenomenon in mice (Hotchin & Benson, I963) , since our investigations have not yet confirmed that this is mediated by defective virus.
